154 related articles for article (PubMed ID: 23866670)
1. [Advances on effects of triptolide with non-small cell lung cancer].
Wang L; Song Y
Zhongguo Fei Ai Za Zhi; 2013 Jul; 16(7):378-81. PubMed ID: 23866670
[TBL] [Abstract][Full Text] [Related]
2. The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer.
Reno TA; Tong SW; Wu J; Fidler JM; Nelson R; Kim JY; Raz DJ
BMC Cancer; 2016 Jul; 16():439. PubMed ID: 27400883
[TBL] [Abstract][Full Text] [Related]
3. Triptolide induces apoptosis through the calcium/calmodulin‑dependent protein kinase kinaseβ/AMP‑activated protein kinase signaling pathway in non‑small cell lung cancer cells.
Ren T; Tang YJ; Wang MF; Wang HS; Liu Y; Qian X; Chang C; Chen MW
Oncol Rep; 2020 Nov; 44(5):2288-2296. PubMed ID: 33000264
[TBL] [Abstract][Full Text] [Related]
4. The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking.
Zou T; Huang Y; Hu Y; Wu M; Zhao Y; Du F; Li M; Wu X; Ji H; Kaboli PJ; Wang S; Xiao Z; Wu Z
Recent Pat Anticancer Drug Discov; 2021; 16(3):426-435. PubMed ID: 33573560
[TBL] [Abstract][Full Text] [Related]
5. Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer.
Li LB; Yang LX; Liu L; Liu FR; Li AH; Zhu YL; Wen H; Xue X; Tian ZX; Sun H; Li PC; Zhao XG
Acta Pharmacol Sin; 2024 May; 45(5):1060-1076. PubMed ID: 38228910
[TBL] [Abstract][Full Text] [Related]
6. The Roles of Plant-Derived Triptolide on Non-Small Cell Lung Cancer.
Wei J; Yan Y; Chen X; Qian L; Zeng S; Li Z; Dai S; Gong Z; Xu Z
Oncol Res; 2019 Jul; 27(7):849-858. PubMed ID: 30982492
[TBL] [Abstract][Full Text] [Related]
7. Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.
Lu N; Liu J; Liu J; Zhang C; Jiang F; Wu H; Chen L; Zeng W; Cao X; Yan T; Wang G; Zhou H; Lin B; Yan X; Zhang XK; Zeng JZ
PLoS One; 2012; 7(4):e35722. PubMed ID: 22545132
[TBL] [Abstract][Full Text] [Related]
8. Triptolide inhibits Wnt signaling in NSCLC through upregulation of multiple Wnt inhibitory factors via epigenetic modifications to Histone H3.
Nardi I; Reno T; Yun X; Sztain T; Wang J; Dai H; Zheng L; Shen B; Kim J; Raz D
Int J Cancer; 2018 Nov; 143(10):2470-2478. PubMed ID: 30006924
[TBL] [Abstract][Full Text] [Related]
9. Triptolide and Its Derivatives as Cancer Therapies.
Noel P; Von Hoff DD; Saluja AK; Velagapudi M; Borazanci E; Han H
Trends Pharmacol Sci; 2019 May; 40(5):327-341. PubMed ID: 30975442
[TBL] [Abstract][Full Text] [Related]
10. Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes.
Jiang N; Dong XP; Zhang SL; You QY; Jiang XT; Zhao XG
Mol Med Rep; 2016 Jan; 13(1):153-9. PubMed ID: 26531258
[TBL] [Abstract][Full Text] [Related]
11. Triptolide Inhibits Lung Cancer Cell Migration, Invasion, and Metastasis.
Reno TA; Kim JY; Raz DJ
Ann Thorac Surg; 2015 Nov; 100(5):1817-24; discussion 1824-5. PubMed ID: 26298168
[TBL] [Abstract][Full Text] [Related]
12. Triptolide-Assisted Phosphorylation of p53 Suppresses Inflammation-Induced NF-κB Survival Pathways in Cancer Cells.
Zheng L; Jia J; Dai H; Wan L; Liu J; Hu L; Zhou M; Qiu M; Chen X; Chang L; Kim JY; Reckamp K; Raz DJ; Xia Z; Shen B
Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28533220
[TBL] [Abstract][Full Text] [Related]
13. Triptolide inhibits PDGF-induced proliferation of ASMCs through G0/G1 cell cycle arrest and suppression of the AKT/NF-κB/cyclinD1 signaling pathway.
He S; Chen M; Lin X; Lv Z; Liang R; Huang L
Eur J Pharmacol; 2020 Jan; 867():172811. PubMed ID: 31756335
[TBL] [Abstract][Full Text] [Related]
14. Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer.
Kumar A; Corey C; Scott I; Shiva S; D'Cunha J
PLoS One; 2016; 11(8):e0160783. PubMed ID: 27501149
[TBL] [Abstract][Full Text] [Related]
15. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
[TBL] [Abstract][Full Text] [Related]
16. Triptolide reduces proliferation and enhances apoptosis of human non-small cell lung cancer cells through PTEN by targeting miR-21.
Li X; Zang A; Jia Y; Zhang J; Fan W; Feng J; Duan M; Zhang L; Huo R; Jiao J; Zhu X
Mol Med Rep; 2016 Mar; 13(3):2763-8. PubMed ID: 26847601
[TBL] [Abstract][Full Text] [Related]
17. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
18. Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180.
Lin Y; Yang X; Lu M; Zheng W; Zhang J; Zhuang H; Hua ZC
Anticancer Drugs; 2013 Oct; 24(9):945-57. PubMed ID: 23958791
[TBL] [Abstract][Full Text] [Related]
19. Triptolide Suppressed the Microglia Activation to Improve Spinal Cord Injury Through miR-96/IKKβ/NF-κB Pathway.
Huang Y; Zhu N; Chen T; Chen W; Kong J; Zheng W; Ruan J
Spine (Phila Pa 1976); 2019 Jun; 44(12):E707-E714. PubMed ID: 31150368
[TBL] [Abstract][Full Text] [Related]
20. Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway.
Park B; Sung B; Yadav VR; Chaturvedi MM; Aggarwal BB
Biochem Pharmacol; 2011 Nov; 82(9):1134-44. PubMed ID: 21820422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]